Sort
51,570 grants matching “autoimmune disease”
CONTROL OF T CELL SYNAPSE STABILIZATION AND SIGNALING
$575,229Matthew F Krummel · University Of California, San Francisco · R37 · FY2024 · AI
CONTROL OF T CELL SYNAPSE STABILIZATION AND SIGNALING
$575,132Matthew F Krummel · University Of California, San Francisco · R37 · FY2023 · AI
Genes that Mediate Tolerance to the Placental Allograft
$575,102Scripps Research Institute · R01 · FY2003 · AI
Dissecting dynamic genetic effects from thymus development to immune-mediated disease
$575,055Hannah Verena Meyer · Cold Spring Harbor Laboratory · R01 · FY2024 · AI
Dissecting dynamic genetic effects from thymus development to immune-mediated disease
$575,055Hannah Verena Meyer · Cold Spring Harbor Laboratory · R01 · FY2023 · AI
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
$575,021Carrie L. Lucas · Yale University · R01 · FY2024 · AI
Prediction and Significance of Cancer in Idiopathic Inflammatory Myositis
$575,021Christopher Mecoli · Johns Hopkins University · R01 · FY2024 · AR
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$575,015Michael R Wilson · University Of California, San Francisco · R01 · FY2024 · NS
Subconcussive neurodegenerative progression in adolescent athletes
$574,980Keisuke Kawata · Trustees Of Indiana University · R01 · FY2024 · NS
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$574,829Emmanuel J Mignot · Stanford University · U01 · FY2025 · NS
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
$574,828Christine C Johnson · Henry Ford Health System · R01 · FY2011 · CA
Ultrasound-activated microbubbles for targeted siRNA delivery to tumor
$574,801Flordeliza S Villanueva · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · EB
Modified HER-2 Tumor Antigens for Vaccination in Cancer
$574,787Mark J. Mamula · L2 Diagnostics, Llc · R42 · FY2007 · CA
LY-1 B Cells: Developmental Origins and V Gene Biases
$574,772Richard R Hardy · Research Inst Of Fox Chase Can Ctr · R01 · FY2009 · AI
Finding the optimal balance of immunotherapy efficacy and toxicity.
$574,731David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2022 · AI
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
$574,590Brian Barkley Graham · University Of California, San Francisco · R01 · FY2023 · HL
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
$574,568Alberto Ascherio · Harvard School Of Public Health · R01 · FY2014 · NS
Immune and metabolic dysfunction during aging in human cohorts
$574,509Blanca I Restrepo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · AG
Personalized, antigen-directed immunotherapy delivered to lymph nodes
$574,500Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
MRI-Controllable Microscale Electronics for Minimally-Invasive Wireless Bio-Sensors and Bio-Actuators
$574,410Manuel Monge · University Of Southern California · R21 · FY2020 · EB
Innate activation and death signals in health and disease
$574,409Edward S. Mocarski · Emory University · R01 · FY2016 · AI
Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs
$574,400Jun J. Yang · St. Jude Children'S Research Hospital · R35 · FY2024 · GM
Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs
$574,400Jun J. Yang · St. Jude Children'S Research Hospital · R35 · FY2025 · GM
Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs
$574,400Jun J. Yang · St. Jude Children'S Research Hospital · R35 · FY2021 · GM
Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs
$574,400Jun J. Yang · St. Jude Children'S Research Hospital · R35 · FY2022 · GM